Salarius(退市)

$Salarius(SLRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001615219-25-000187  Size: 400 KB 网页链接

$Salarius(SLRX)$ 8-K Current report, item 5.07 Accession Number: 0001615219-26-000003  Act: 34  Size: 153 KB 网页链接

$Salarius(SLRX)$ 8-K Current report, item 3.01 Accession Number: 0001615219-26-000005  Act: 34  Size: 140 KB 网页链接

$Salarius(SLRX)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001628280-25-051365  Act: 33  Size: 1 MB 网页链接

$Salarius(SLRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001649553-25-000209  Act: 34  Size: 15 KB 网页链接

$Salarius(SLRX)$ 8-K Current report, items 5.03, 8.01, and 9.01 Accession Number: 0001615219-26-000013  Act: 34  Size: 470 KB 网页链接

$Salarius(SLRX)$ 这份于2025年11月14日提交的附表13G文件，报告了Mitchell P. Kopin、Daniel B. Asher和Intracoastal Capital LLC对Salarius Pharmaceuticals, Inc.普通股的实益所有权。文件显示，每位报告人可能被视为实益拥有187,295股普通股，约占已发行股份的4.99%。这些股份受Intracoastal C...

$Salarius(SLRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001615219-25-000177  Size: 5 KB 网页链接

$Salarius(SLRX)$ 8-K Current report, items 5.07, 7.01, and 9.01 Accession Number: 0001615219-25-000197  Act: 34  Size: 166 KB 网页链接

$Salarius(SLRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001615219-26-000004  Size: 6 KB 网页链接

$Salarius(SLRX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-25-335395  Act: 34  Size: 455 KB 网页链接

$Salarius(SLRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001615219-25-000164  Act: 34  Size: 3 MB 网页链接

$Salarius(SLRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001615219-25-000193  Size: 5 KB 网页链接

$Salarius(SLRX)$ 8-K Current report, item 7.01 Accession Number: 0001615219-25-000166  Act: 34  Size: 144 KB 网页链接

$Salarius(SLRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001615219-25-000185  Size: 403 KB 网页链接

$Salarius(SLRX)$ 8-K Current report, items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 8.01, and 9.01 Accession Number: 0001615219-25-000162  Act: 34  Size: 880 KB 网页链接

$Salarius(SLRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-26-008944  Act: 34  Size: 863 KB 网页链接

$Salarius(SLRX)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001615219-25-000157  Act: 34  Size: 4 MB 网页链接

$Salarius(SLRX)$ 8-K Current report, item 5.02 Accession Number: 0001615219-25-000168  Act: 34  Size: 368 KB 网页链接

$Salarius(SLRX)$ CVI投资公司及Heights资本管理公司已向美国证券交易委员会（SEC）提交了13G表格，报告其持有Salarius制药公司9.9%的普通股实益所有权。文件显示，Heights资本管理公司作为CVI投资公司的投资管理人，可能对CVI投资公司所持股份行使投票权及处置权。报告股份包括30万股普通股及可通...